Citizens Maintains Market Outperform on Axogen, Raises Price Target to $55
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsPrice Target
Citizens analyst David Turkaly maintains Axogen (NASDAQ:AXGN) with a Market Outperform and raises the price target from $50 to $55.
Citizens analyst David Turkaly maintains Axogen (NASDAQ:AXGN) with a Market Outperform and raises the price target from $50 to $55.